Company / Working Capital
FENNEC PHARMACEUTICALS INC. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$56.5M
FY2025
5-year range
$11.6M / $56.5M
FY2021-FY2025
Trend
+51.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $19M to $57M over the past 2 years.
Based on SEC 10-K filings.
$57M in FY2025.
Improved from $19M to $57M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital increased 51.9% year-over-year.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $56.5M | +51.9% |
| FY2024 | $37.2M | +92.7% |
| FY2023 | $19.3M | -6.9% |
| FY2021 | $20.7M | +78.5% |
| FY2019 | $11.6M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026